Mikkael Sekeres, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients (NCT04539236) | Mikkael Sekeres, MD | 2021-11-09 |
Track Mikkael Sekeres, MD automatically
Every clearance here is in the API, with alerts when new ones post.